Fieldview Capital Management Boosts Align Technology Stake

The investment firm purchased over 7,900 shares of the medical equipment provider in Q3 2025.

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Fieldview Capital Management LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) during the third quarter of 2025, according to a recent SEC filing. The firm bought 7,936 shares of the medical equipment provider's stock, valued at approximately $994,000.

Why it matters

Align Technology is a leading provider of clear aligners and intraoral scanners for the dental industry. The company's Invisalign system has become a popular alternative to traditional metal braces. This investment by Fieldview Capital Management suggests the firm sees growth potential in Align Technology's business.

The details

According to the SEC filing, Fieldview Capital Management purchased the 7,936 shares of Align Technology during the third quarter of 2025. The shares were valued at approximately $994,000. Other institutional investors have also recently modified their holdings of the company, with some increasing their positions and others reducing their stakes.

  • Fieldview Capital Management purchased the Align Technology shares during the third quarter of 2025.

The players

Fieldview Capital Management LLC

An investment management firm that purchased a new position in shares of Align Technology, Inc.

Align Technology, Inc.

A medical equipment provider that specializes in clear aligners and intraoral scanners for the dental industry.

Got photos? Submit your photos here. ›

The takeaway

This investment by Fieldview Capital Management suggests the firm sees long-term growth potential in Align Technology's dental technology products, particularly the popular Invisalign clear aligner system. As the company continues to innovate and expand its market share, it could attract further interest from institutional investors.